Basilea Pharmaceutica AG (BPMUF)
USD 52.83
(0.0%)
USD 52.83
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 157.63 Million | 147.76 Million | 148.12 Million | 127.62 Million | 134.38 Million | 132.55 Million |
| Cost of Revenue | 26.79 Million | 24.6 Million | 24.07 Million | 24.05 Million | 18.86 Million | 20.29 Million |
| Gross Profit | 130.84 Million | 123.16 Million | 124.05 Million | 103.57 Million | 115.51 Million | 112.25 Million |
| Operating Expenses | 33.78 Million | 102.34 Million | 121.04 Million | 124.98 Million | 131.17 Million | 136.35 Million |
| Selling, General and Administrative Expenses | 33.78 Million | 30.81 Million | 29.72 Million | 29.42 Million | 30.05 Million | 31.4 Million |
| Research and Development Expenses | 77.85 Million | 73.8 Million | 93.15 Million | 97.41 Million | 102.66 Million | 104.94 Million |
| Other Expenses | -75.14 Million | 852 Thousand | -1.23 Million | - | - | - |
| Cost and Expenses | 138.42 Million | 126.95 Million | 145.11 Million | 149.04 Million | 150.04 Million | 156.65 Million |
| Operating Income | 19.2 Million | 18.54 Million | 1.18 Million | -8.22 Million | -17.2 Million | -24.09 Million |
| Interest Expense | 11.2 Million | 9.84 Million | 8.15 Million | 7.58 Million | 6.42 Million | 6.55 Million |
| Income Tax Expense | 10 Thousand | -45 Thousand | 37 Thousand | 55 Thousand | 40 Thousand | 192 Thousand |
| Earnings before Tax | 10.46 Million | 12.1 Million | -6.79 Million | -14.66 Million | -22.38 Million | -31.16 Million |
| Net Income | 10.45 Million | 12.14 Million | -6.83 Million | -14.72 Million | -22.42 Million | -31.35 Million |
| Earnings Per Share Basic | 0.86 | 1.02 | -0.58 | -1.43 | -2.08 | -2.89 |
| Earnings Per Share Diluted | 0.86 | 1.02 | -0.58 | -1.43 | -2.08 | -2.89 |
| Weighted Average Shares Outstanding | 12.15 Million | 11.86 Million | 11.68 Million | 10.28 Million | 10.75 Million | 10.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.14 Million | 11.94 Million | 11.68 Million | 10.28 Million | 10.75 Million | 10.83 Million |
| Gross Margin | 0.83 | 0.83 | 0.84 | 0.81 | 0.86 | 0.85 |
| EBIT Margin | 0.15 | 0.16 | 0.02 | -0.16 | -0.11 | -0.17 |
| Profit Margin | 0.07 | 0.08 | -0.05 | -0.12 | -0.17 | -0.24 |
| EBITDA | 23.24 Million | 23.04 Million | 2.11 Million | -5.88 Million | -14.31 Million | -22.24 Million |
| Earnings Before Tax Margin | 0.12 | 0.13 | 0.01 | -0.06 | -0.13 | -0.18 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 38.14 Million | 38.14 Million | 72.72 Million | 157.63 Million | 36.36 Million | 84.9 Million |
| Cost of Revenue | 25.85 Million | 25.85 Million | 16.79 Million | 26.79 Million | 36.59 Million | 9.99 Million |
| Gross Profit | 12.28 Million | 12.28 Million | 55.93 Million | 130.84 Million | -227 Thousand | 74.9 Million |
| Operating Expenses | 7.66 Million | 7.66 Million | 73.62 Million | 108.93 Million | 8.37 Million | 38.01 Million |
| Selling, General and Administrative Expenses | 7.53 Million | 7.53 Million | 17.23 Million | - | 7.96 Million | 16.54 Million |
| Research and Development Expenses | 16.79 Million | 16.79 Million | 56.38 Million | - | 28.19 Million | 21.46 Million |
| Other Expenses | -16.66 Million | -16.66 Million | - | -1.93 Million | - | - |
| Cost and Expenses | 33.51 Million | 33.51 Million | 90.42 Million | 135.72 Million | 44.96 Million | 48 Million |
| Operating Income | 4.62 Million | 4.62 Million | -17.69 Million | 19.2 Million | -8.18 Million | 36.89 Million |
| Interest Expense | 3.81 Million | - | 9.76 Million | 11.2 Million | - | 5.79 Million |
| Income Tax Expense | 6.7 Million | 6.7 Million | -17 Thousand | 10 Thousand | 8500.00 | 27 Thousand |
| Earnings before Tax | 3.66 Million | 3.66 Million | -21.4 Million | 10.46 Million | -10.7 Million | 31.86 Million |
| Net Income | 10.36 Million | 10.36 Million | -21.38 Million | 10.45 Million | -10.69 Million | 31.84 Million |
| Earnings Per Share Basic | 0.81 | 0.81 | -1.78 | - | -0.95 | 2.66 |
| Earnings Per Share Diluted | 0.75 | 0.75 | -1.78 | - | -0.89 | 2.31 |
| Weighted Average Shares Outstanding | 12.85 Million | 12.85 Million | 12 Million | 11.99 Million | 11.23 Million | 11.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.82 Million | 13.82 Million | 12 Million | 12.14 Million | 12 Million | 13.78 Million |
| Gross Margin | 0.32 | 0.32 | 0.77 | 0.83 | -0.01 | 0.88 |
| EBIT Margin | 0.13 | 0.13 | -0.22 | - | -0.22 | 0.46 |
| Profit Margin | 0.27 | 0.27 | -0.29 | 0.07 | -0.29 | 0.38 |
| EBITDA | 5.07 Million | 5.07 Million | -15.96 Million | - | -7.87 Million | 38.65 Million |
| Earnings Before Tax Margin | 0.12 | 0.12 | -0.24 | 0.12 | -0.23 | 0.43 |
0N0B
ALNLF
2789
0804
AVB
9267